AZU1
Basic information
Region (hg38): 19:825097-832018
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (54 variants)
- not_provided (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AZU1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000001700.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 54 | 54 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 54 | 0 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AZU1 | protein_coding | protein_coding | ENST00000233997 | 5 | 6921 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000391 | 0.398 | 125571 | 0 | 124 | 125695 | 0.000493 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.132 | 175 | 180 | 0.972 | 0.0000127 | 1601 |
Missense in Polyphen | 65 | 68.568 | 0.94797 | 637 | ||
Synonymous | -0.474 | 86 | 80.6 | 1.07 | 0.00000606 | 551 |
Loss of Function | 0.246 | 7 | 7.74 | 0.905 | 3.32e-7 | 81 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000902 | 0.000891 |
Ashkenazi Jewish | 0.00164 | 0.00159 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.000287 | 0.000231 |
European (Non-Finnish) | 0.000547 | 0.000528 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.000501 | 0.000490 |
Other | 0.000501 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: This is a neutrophil granule-derived antibacterial and monocyte- and fibroblast-specific chemotactic glycoprotein. Binds heparin. The cytotoxic action is limited to many species of Gram- negative bacteria; this specificity may be explained by a strong affinity of the very basic N-terminal half for the negatively charged lipopolysaccharides that are unique to the Gram-negative bacterial outer envelope. It may play a role in mediating recruitment of monocytes in the second wave of inflammation. Has antibacterial activity against the Gram-negative bacterium P.aeruginosa, this activity is inhibited by LPS from P.aeruginosa. Acting alone, it does not have antimicrobial activity against the Gram-negative bacteria A.actinomycetemcomitans ATCC 29532, A.actinomycetemcomitans NCTC 9709, A.actinomycetemcomitans FDC-Y4, H.aphrophilus ATCC 13252, E.corrodens ATCC 23834, C.sputigena ATCC 33123, Capnocytophaga sp ATCC 33124, Capnocytophaga sp ATCC 27872 or E.coli ML-35. Has antibacterial activity against C.sputigena ATCC 33123 when acting synergistically with either elastase or cathepsin G. {ECO:0000269|PubMed:1399008, ECO:0000269|PubMed:1937776, ECO:0000269|PubMed:2312733}.;
- Pathway
- Neutrophil degranulation;Innate Immune System;Immune System
(Consensus)
Recessive Scores
- pRec
- 0.400
Intolerance Scores
- loftool
- 0.258
- rvis_EVS
- 0.4
- rvis_percentile_EVS
- 76.31
Haploinsufficiency Scores
- pHI
- 0.116
- hipred
- N
- hipred_score
- 0.180
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.145
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- microglial cell activation;proteolysis;inflammatory response;protein kinase C-activating G protein-coupled receptor signaling pathway;glial cell migration;positive regulation of gene expression;positive regulation of peptidyl-threonine phosphorylation;antimicrobial humoral response;calcium-mediated signaling using intracellular calcium source;monocyte activation;positive regulation of tumor necrosis factor biosynthetic process;negative regulation of apoptotic process;regulation of vascular permeability;neutrophil degranulation;cellular extravasation;positive regulation of MHC class II biosynthetic process;positive regulation of cell adhesion;positive regulation of protein kinase activity;macrophage chemotaxis;positive regulation of interleukin-1 beta biosynthetic process;positive regulation of fractalkine biosynthetic process;positive regulation of phagocytosis;defense response to Gram-negative bacterium;induction of positive chemotaxis;defense response to virus;cell chemotaxis;protein kinase C signaling;neutrophil mediated killing of bacterium
- Cellular component
- extracellular region;extracellular space;extrinsic component of membrane;azurophil granule membrane;azurophil granule lumen;azurophil granule;extracellular exosome
- Molecular function
- serine-type endopeptidase activity;protein binding;heparin binding;peptidase activity;toxic substance binding;heparan sulfate proteoglycan binding